Registry for Advanced Endoscopy

Research Registry for Endoscopic Treatment and Diagnostics

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05187312

Acronym

ERDB

Enrollment

1000

Registered

2022-01-11

Start date

2022-01-14

Completion date

2032-01-14

Last updated

2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma, Pancreatic Cancer, Sclerosing Cholangitis

Brief summary

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

Interventions

PROCEDUREEndoscopic retrograde Cholangio- pancreatography

Endoscopic intervention in the biliary or pancreatic duct

PROCEDUREEndoscopic ultrasound

Endoscopic investigation/intervention with ultrasound

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical indication for endoscopic intervention/procedure

Exclusion criteria

* No informed consent * Age \<18 years

Design outcomes

Primary

Measure	Time frame	Description
Adverse events	30-days and 60-days post-procedure	Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event
Diagnostic yield	1-year follow up	Diagnostic yield after tissue sampling

Countries

Sweden

Contacts

Primary ContactErik von Seth, MD, PhD

erik.von.seth@ki.se+46812380000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026